Cohen & Steers
CNS (NYSE)
Cohen & Steers (CNS) is an attractive option for investors seeking solid dividend growth, currently undervalued by approximately 34%. With a forward dividend yield of 3.70% and a robust 5-year dividend growth rate of 12.6%, it presents a compelling case for those focused on reliable income from financially healthy companies. Analysts maintain a mixed outlook, with a median price target of $87.50, suggesting potential for upside despite recent performance challenges, including a 19.36% decline over the past year.
Pros:
- Undervalued by 34%
- 12.6% 5-year dividend growth
Cons:
- Negative 1-year return
- Market volatility risk
Cohen & Steers (CNS) may be suitable for income-focused investors seeking exposure to dividend growth, particularly those who can tolerate short-term volatility given its recent performance. While the stock's current valuation suggests potential for recovery, cautious investors should weigh the mixed analyst outlook against the backdrop of its recent returns.